Bendeka™ (bendamustine) – New warnings
February 9, 2017 – The FDA approved new warnings to the Warnings and Precautions section of the Bendeka (bendamustine) drug label regarding hepatotoxicity and drug reaction with eosinophilia and systemic symptoms (DRESS).
Download PDF
